Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease.
Intracranial transplantation of neural stem cells (NSCs) delayed disease onset, preserved motor function, reduced pathology and prolonged survival in a mouse model of Sandhoff disease, a lethal gangliosidosis. Although donor-derived neurons were electrophysiologically active within chimeric regions,...
Main Authors: | Lee, J, Jeyakumar, M, Gonzalez, R, Takahashi, H, Lee, P, Baek, R, Clark, D, Rose, H, Fu, G, Clarke, J, McKercher, S, Meerloo, J, Muller, F, Park, K, Butters, T, Dwek, R, Schwartz, P, Tong, G, Wenger, D, Lipton, SA, Seyfried, T, Platt, F, Snyder, E |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2007
|
Similar Items
-
Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis.
by: Jeyakumar, M, et al.
Published: (2002) -
Storage solutions: treating lysosomal disorders of the brain.
by: Jeyakumar, M, et al.
Published: (2005) -
New developments in treating glycosphingolipid storage diseases.
by: Platt, F, et al.
Published: (2005) -
N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal Sandhoff disease mice.
by: Baek, R, et al.
Published: (2008) -
N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal sandhoff diseased mice
by: Baek, R, et al.
Published: (2004)